AVITA Medical Inc (NASDAQ:RCEL)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RCEL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RCEL

  • Market Cap$512.760m
  • SymbolNASDAQ:RCEL
  • IndustryHealthcare
  • SectorMedical Devices
  • Currency
  • ISINUS05380C1027

Company Profile

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly. Avita is domiciled, and has its primary listing, in the U.S.Avita Medical Ltd is engaged in developing and distributing regenerative products for the treatment of a range of wounds, scars, and skin defects. The company’s lead product ReCell is used in the treatment of a variety of burns, plastic, and others.

Latest RCEL news

Currently there for this company. Visit our news hub for other news .